PUBLISHER: The Business Research Company | PRODUCT CODE: 2133847
PUBLISHER: The Business Research Company | PRODUCT CODE: 2133847
Robot-assisted percutaneous coronary intervention (R-PCI) is a minimally invasive technique in which robotic systems assist in navigating catheters, balloons, and stents to open narrowed or blocked coronary arteries. It provides greater precision, stability, and control while minimizing human error. The approach also reduces radiation exposure for patients and medical staff, with the aim of improving procedural safety, efficiency, and overall clinical outcomes.
The primary component types of robot-assisted percutaneous coronary intervention (PCI) are robotic systems, catheters and guidewires, and control consoles. Robotic systems are sophisticated machines designed to assist physicians in performing PCI by remotely controlling guidewires, balloons, and stents from a protected workstation. They are applied in various procedures such as coronary angioplasty, stent placement, and thrombectomy, and are used by several end users, including hospitals, cardiac catheterization laboratories, ambulatory surgical centers, and others.
Tariffs are influencing the robot-assisted PCI market by increasing the cost of imported robotic components, imaging units, and precision electromechanical systems. Robotic systems and control console segments are particularly affected, especially in regions such as North America and Asia-Pacific that depend on global supply chains for advanced medical robotics. These cost pressures have slowed procurement by some hospitals. However, tariffs are also encouraging local manufacturing, strategic sourcing, and technology partnerships, supporting long-term innovation and regional production capabilities.
The robot-assisted percutaneous coronary intervention (pci) market research report is one of a series of new reports from The Business Research Company that provides robot-assisted percutaneous coronary intervention (pci) market statistics, including robot-assisted percutaneous coronary intervention (pci) industry global market size, regional shares, competitors with a robot-assisted percutaneous coronary intervention (pci) market share, detailed robot-assisted percutaneous coronary intervention (pci) market segments, market trends and opportunities, and any further data you may need to thrive in the robot-assisted percutaneous coronary intervention (pci) industry. This robot-assisted percutaneous coronary intervention (pci) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The robot-assisted percutaneous coronary intervention (pci) market size has grown exponentially in recent years. It will grow from $0.03 billion in 2025 to $0.04 billion in 2026 at a compound annual growth rate (CAGR) of 26.4%. The growth in the historic period can be attributed to increasing prevalence of coronary artery disease, limitations in the precision of manual PCI procedures, growing use of catheter-based interventions, rising awareness of radiation exposure risks, and expansion of cardiac catheterization laboratories.
The robot-assisted percutaneous coronary intervention (pci) market size is expected to see exponential growth in the next few years. It will grow to $0.11 billion in 2030 at a compound annual growth rate (CAGR) of 26.0%. The growth in the forecast period can be attributed to advancements in robotic-assisted intervention technologies, increasing adoption of automation in cardiology, rising investment in digital healthcare infrastructure, growing demand for complex and high-risk PCI procedures, and supportive regulatory approvals for robotic systems. Major trends in the forecast period include rising adoption of minimally invasive cardiac procedures, growing focus on reducing radiation exposure for clinicians, increasing demand for precision and procedural accuracy, expansion of complex coronary intervention capabilities, and improved patient safety and clinical outcomes.
The increasing prevalence of cardiovascular diseases is expected to propel the growth of the robot-assisted percutaneous coronary intervention (PCI) market in the coming years. Cardiovascular diseases refer to a group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, heart attacks, and stroke. The rise in cardiovascular diseases is largely associated with sedentary lifestyles, which contribute to obesity, hypertension, and poor heart health. Robot-assisted percutaneous coronary intervention (PCI) treats cardiovascular diseases by accurately reopening blocked or narrowed coronary arteries to restore blood flow to the heart while reducing procedural risks and radiation exposure, thereby improving patient outcomes. For instance, in December 2024, GOV.UK, a UK-based government agency, reported that in March 2024, nearly 2.24 million adults in England, representing about 4.4% of those aged 18 and over, had a GP-recorded diagnosis of CKD. This reflected an increase from 2.09 million cases in the previous year. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the robot-assisted percutaneous coronary intervention (PCI) market.
Major companies operating in the robot-assisted percutaneous coronary intervention (PCI) market are focusing on developing advanced robotic cardiology platforms to improve patient safety and streamline complex coronary interventions. A robotic cardiology platform is a high-tech system that assists cardiologists in performing accurate and controlled coronary procedures while enhancing precision, minimizing human error, and reducing radiation exposure for patients and medical staff. For instance, in May 2023, Robocath SAS, a France-based company specializing in robotic solutions for vascular interventions, launched the R-One+. This advanced robotic solution enables interventional cardiologists to perform coronary angioplasties (percutaneous coronary intervention, or PCI) by controlling devices through an integrated command unit located in the catheterization lab or control room. The R-One+ enhances precision in device manipulation, improves safety for both patients and medical staff by reducing radiation exposure, and provides more comfortable working conditions for operators. The launch was marked at the EuroPCR conference in Paris, where the platform demonstrated new capabilities designed to make PCI procedures easier and safer while protecting the cardiology team from radiation-induced injuries. This innovation reflects Robocath's commitment to improving cardiovascular disease treatments through smart robotic assistance.
In April 2024, Microbot Medical, a US-based developer of robotic endovascular systems and minimally invasive vascular solutions, partnered with Corewell Health. The partnership between Microbot Medical Inc. and Corewell Health aims to enable and advance remote telesurgery through the use of Microbot's LIBERTY Endovascular Robotic Surgical System. Corewell Health is a US-based healthcare company that provides robotic-assisted procedures and enhances patient care in cardiovascular interventions.
Major companies operating in the robot-assisted percutaneous coronary intervention (pci) market are Medtronic plc, Siemens Healthineers AG, Boston Scientific Corporation, Intuitive Surgical, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Group Holdings Limited, Stereotaxis Inc., Perfint Healthcare, Robocath Inc., Meril Life Sciences Pvt. Ltd., Abbott Laboratories, Philips Healthcare, Terumo Corporation, Asahi Intecc, Catheter Precision, Cardiobot, Remedics, meerecompany Inc., AngioDynamics, Clear Surgical Inc., GE Healthcare, Canon Medical Systems, Asensus Surgical, Endovascular Robotics
North America was the largest region in the robot-assisted percutaneous coronary intervention (PCI) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robot-assisted percutaneous coronary intervention (pci) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the robot-assisted percutaneous coronary intervention (pci) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The robot-assisted percutaneous coronary intervention (PCI) market consists of revenues earned by entities by providing services such as robotic catheter navigation, remote-controlled stent placement, real-time imaging integration, and procedural planning support. The market value includes the value of related goods sold by the service provider or included within the service offering. The robot-assisted percutaneous coronary intervention (PCI) market also includes sales of radiation shielding accessories, robotic arm components, monitoring and display units, integration interfaces, and sterile disposable kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses robot-assisted percutaneous coronary intervention (pci) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for robot-assisted percutaneous coronary intervention (pci) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The robot-assisted percutaneous coronary intervention (pci) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.